Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Transplantation|July 16, 2008
Randomization is essential for progress in transplant medicineColin Baigent, Jonathan R Emberson
European Heart Journal|December 5, 2013
Air pollution and traffic noise: do they cause atherosclerosis?Benjamin J Cairns, Colin Baigent
European Heart Journal|July 8, 2019
Variability in aspirin efficacy: all in the genes?Colin Baigent, Michael V Holmes
European Heart Journal|September 9, 2025
Estimating the long-term effects of aspirin for primary preventionColin Baigent, Alistair Roddick, Carlo Patrono
Current Opinion in Nephrology and Hypertension|October 16, 2004
Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trialsColin Baigent, Martin Landray, Marion Warren
BMJ (Clinical Research Ed.)|January 19, 2002
Article makes simple errors and could cause unnecessary deathsColin Baigent, Rory Collins, Richard Peto
Lancet (London, England)|October 7, 2014
Misrepresentation of statin safety evidenceJane Armitage, Colin Baigent, Rory Collins
Lancet (London, England)|November 10, 2016
Lessons from the controversy over statins - Authors' replyJane Armitage, Colin Baigent, Rory Collins
Journal of Lipid Research|January 31, 2018
The role of lipoprotein (a) in chronic kidney diseaseJemma C Hopewell, Richard Haynes, Colin Baigent
Nature Clinical Practice. Cardiovascular Medicine|January 5, 2006
Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesisCharles H Hennekens, Danielle Hollar, Colin Baigent
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Transplantation|July 16, 2008
Randomization is essential for progress in transplant medicineColin Baigent, Jonathan R Emberson
European Heart Journal|December 5, 2013
Air pollution and traffic noise: do they cause atherosclerosis?Benjamin J Cairns, Colin Baigent
European Heart Journal|July 8, 2019
Variability in aspirin efficacy: all in the genes?Colin Baigent, Michael V Holmes
European Heart Journal|September 9, 2025
Estimating the long-term effects of aspirin for primary preventionColin Baigent, Alistair Roddick, Carlo Patrono
Current Opinion in Nephrology and Hypertension|October 16, 2004
Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trialsColin Baigent, Martin Landray, Marion Warren
BMJ (Clinical Research Ed.)|January 19, 2002
Article makes simple errors and could cause unnecessary deathsColin Baigent, Rory Collins, Richard Peto
Lancet (London, England)|October 7, 2014
Misrepresentation of statin safety evidenceJane Armitage, Colin Baigent, Rory Collins
Lancet (London, England)|November 10, 2016
Lessons from the controversy over statins - Authors' replyJane Armitage, Colin Baigent, Rory Collins
Journal of Lipid Research|January 31, 2018
The role of lipoprotein (a) in chronic kidney diseaseJemma C Hopewell, Richard Haynes, Colin Baigent
Nature Clinical Practice. Cardiovascular Medicine|January 5, 2006
Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesisCharles H Hennekens, Danielle Hollar, Colin Baigent
Pageof 18